Overcoming Barriers to Homegrown CAR-TCR Development in Low & Middle Income Countries (LMICs)

• Examine key challenges in developing CAR-TCR therapies from bench to bedside in low- and middle-income countries, from infrastructure to funding gaps
• Share practical solutions to reduce costs, strengthen local manufacturing capacity, and accelerate clinical translation
• Present clinical data showcasing progress and potential for scalable, sustainable innovation in LMIC settings

Speakers:

Albeena Nisar

Scientific, Car T Cell Therapy Centre & cGMP Cell Therapy Unit Project Officer

Tata Memorial Centre